M&As this week: Guanhao Biotech, Arterium Corporation

11th August 2016 (Last Updated August 11th, 2016 18:30)

Biotechnology company Guanhao Biotech has announced its acquirement of a 5% stake within a pharmaceutical company based in Beijing, China.

Biotechnology company Guanhao Biotech has announced its acquirement of a 5% stake within a pharmaceutical company based in Beijing, China.

The company expects the acquisition to cost up to $2.4m.

Arterium Corporation has acquired Marifarm, proizvodnja in storitve d.o.o. from Nova KBM for a purchase consideration of $7.54m.

The acquisition enables the acquirer and the acquired companies to strengthen their pharmaceutical research and development (R&D) and production capabilities.